Trial intelligence / Profile preview

GSK2036874A Booster in Healthy Toddlers

NCT01106092Phase 2Completed

Sponsor
GSK
Start
May 2010
Primary completion
Sep 2010
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of GSK2036874A in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by GSK. Started May 2010; status: completed.

02

Drugs

GSK2036874A
03

Conditions

diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis

Beyond the preview

Go deeper on NCT01106092.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01106092.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call